Effect of subcutaneous administration of octreotide on endogenous vasoactive systems and renal function in cirrhotic patients with ascites

被引:34
|
作者
Sàbat, M
Guarner, C
Soriano, G
Bulbena, O
Novella, MT
Ortiz, J
Ricart, E
Villanueva, C
Rosello, J
Rodríguez, J
Balanzó, J
机构
[1] Hosp St Creu & St Pau, Dept Gastroenterol, Liver Sect, Barcelona 08025, Spain
[2] CSIC, Inst Invest Biomed, Barcelona, Spain
[3] Hosp St Creu & St Pau, Dept Biochem, Barcelona, Spain
关键词
cirrhosis; ascites; octreotide; plasma renin activity; glucagon; nitric oxide;
D O I
10.1023/A:1026698001921
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Splanchnic and systemic arteriolar vasodilation plays an important role in ascites formation in cirrhosis. Octreotide produces splanchnic vasoconstriction, but the effects on systemic hemodynamics and renal function are controversial. This study evaluated the effect of subcutaneous octreotide administration on systemic hemodynamics, endogenous vasoactive systems, and renal function in cirrhotic patients with ascites. Twenty patients were included: 10 received octreotide 250 mu g/12 hr subcutaneously (for five days), and 10 did not. No statistically significant changes were found in mean arterial pressure and cardiac rate. Octreotide induced a statistically significant decrease in plasma renin activity (P < 0.01), plasma aldosterone (P = 0.01) and plasma glucagon (P < 0.05). No significant variations were observed in other systemic vasoactive substances (nitric oxide and prostacyclin). Renal function was not modified in either group. In conclusion, in cirrhotic patients with ascites, subcutaneous octreotide administration decreases plasma glucagon, renin activity, and aldosterone without changing in systemic hemodynamics or renal function.
引用
收藏
页码:2184 / 2189
页数:6
相关论文
共 50 条
  • [1] Effect of Subcutaneous Administration of Octreotide on Endogenous Vasoactive Systems and Renal Function in Cirrhotic Patients with Ascites
    Miriam Sabat
    Carlos Guarner
    German Soriano
    Oriol Bulbena
    Maria Teresa Novella
    Jordi Ortiz
    Elena Ricart
    Candid Villanueva
    Joan Rosello
    Jose Rodriguez
    Joaquim Balanzo
    Digestive Diseases and Sciences, 1998, 43 : 2184 - 2189
  • [2] EFFECT OF OCTREOTIDE ON ENDOGENOUS VASOACTIVE SYSTEMS AND RENAL-FUNCTION IN CIRRHOTIC-PATIENTS WITH ASCITES
    SABAT, M
    SORIANO, G
    MOURELLE, M
    NOVELLA, MT
    ORTIZ, J
    BULBENA, O
    ROSELLO, J
    GUARNER, C
    VILARDELL, F
    HEPATOLOGY, 1995, 22 (04) : 222 - 222
  • [3] Effect of human albumin infusion on renal functions and endogenous vasoactive agents in cirrhotic patients with ascites.
    Bozbas, A
    Bahar, K
    Akbay, A
    Kr, M
    Demirtas, S
    Uzunalimolu, O
    Dokmeci, A
    HEPATOLOGY, 1999, 30 (04) : 295A - 295A
  • [4] PROGNOSTIC VALUE OF ARTERIAL-PRESSURE, ENDOGENOUS VASOACTIVE SYSTEMS, AND RENAL-FUNCTION IN CIRRHOTIC-PATIENTS ADMITTED TO THE HOSPITAL FOR THE TREATMENT OF ASCITES
    LLACH, J
    GINES, P
    ARROYO, V
    RIMOLA, A
    TITO, L
    BADALAMENTI, S
    JIMENEZ, W
    GAYA, J
    RIVERA, F
    RODES, J
    GASTROENTEROLOGY, 1988, 94 (02) : 482 - 487
  • [5] Systemic hemodynamic and renal effects of midodrine and octreotide in cirrhotic patients with ascites
    Kalambokis, Georgios N.
    Tsianos, Epameinondas V.
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2011, 16 (12): : 1636 - 1637
  • [6] The effects of chronic administration of indomethacin and misoprostol on renal function in cirrhotic patients with and without ascites
    Hsia, HC
    Lin, HC
    Tsai, YT
    Lee, FY
    Hwang, CC
    Hou, MC
    Lee, SD
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1995, 30 (12) : 1194 - 1199
  • [7] The effects of chronic treatment with octreotide versus octreotide plus midodrine on systemic hemodynamics and renal hemodynamics and function in nonazotemic cirrhotic patients with ascites
    Kalambokis, G
    Economou, M
    Fotopoulos, A
    Al Bokharhii, J
    Pappas, C
    Katsaraki, A
    Tsianos, EV
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (04): : 879 - 885
  • [8] OCTREOTIDE IMPROVES RENAL-FUNCTION, TOTAL EXCHANGEABLE SODIUM AND PERIPHERAL HEMODYNAMICS IN CIRRHOTIC-PATIENTS WITH ASCITES
    RODRIGUEZPEREZ, F
    ALBILLOS, A
    GROSZMANN, RJ
    GASTROENTEROLOGY, 1993, 104 (04) : A980 - A980
  • [9] Assessment of renal function in cirrhotic patients with ascites.
    Roy, L
    Legault, L
    Spahr, L
    Fenyves, D
    Willems, B
    Vendeville, B
    PomierLayrargues, G
    HEPATOLOGY, 1996, 24 (04) : 1774 - 1774
  • [10] Effect of celecoxib on renal function in cirrhotic patients with ascites. A pilot study
    Guevarra, M
    Abecasis, R
    Jimenez, W
    Rios, H
    Terg, R
    JOURNAL OF HEPATOLOGY, 2002, 36 : 203 - 203